chr8-26634815-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001197293.3(DPYSL2):c.1041C>T(p.Ile347Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000412 in 1,614,222 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0021 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00023 ( 2 hom. )
Consequence
DPYSL2
NM_001197293.3 synonymous
NM_001197293.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.18
Publications
1 publications found
Genes affected
DPYSL2 (HGNC:3014): (dihydropyrimidinase like 2) This gene encodes a member of the collapsin response mediator protein family. Collapsin response mediator proteins form homo- and hetero-tetramers and facilitate neuron guidance, growth and polarity. The encoded protein promotes microtubule assembly and is required for Sema3A-mediated growth cone collapse, and also plays a role in synaptic signaling through interactions with calcium channels. This gene has been implicated in multiple neurological disorders, and hyperphosphorylation of the encoded protein may play a key role in the development of Alzheimer's disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]
DPYSL2 Gene-Disease associations (from GenCC):
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 8-26634815-C-T is Benign according to our data. Variant chr8-26634815-C-T is described in ClinVar as [Benign]. Clinvar id is 712013.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.18 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 Unknown gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYSL2 | NM_001197293.3 | c.1041C>T | p.Ile347Ile | synonymous_variant | Exon 8 of 14 | ENST00000521913.7 | NP_001184222.1 | |
DPYSL2 | NM_001386.6 | c.726C>T | p.Ile242Ile | synonymous_variant | Exon 8 of 14 | NP_001377.1 | ||
DPYSL2 | NM_001244604.2 | c.618C>T | p.Ile206Ile | synonymous_variant | Exon 8 of 14 | NP_001231533.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPYSL2 | ENST00000521913.7 | c.1041C>T | p.Ile347Ile | synonymous_variant | Exon 8 of 14 | 1 | NM_001197293.3 | ENSP00000427985.2 |
Frequencies
GnomAD3 genomes AF: 0.00212 AC: 323AN: 152220Hom.: 2 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
323
AN:
152220
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000577 AC: 145AN: 251442 AF XY: 0.000478 show subpopulations
GnomAD2 exomes
AF:
AC:
145
AN:
251442
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000233 AC: 341AN: 1461884Hom.: 2 Cov.: 31 AF XY: 0.000210 AC XY: 153AN XY: 727246 show subpopulations
GnomAD4 exome
AF:
AC:
341
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
153
AN XY:
727246
show subpopulations
African (AFR)
AF:
AC:
239
AN:
33480
American (AMR)
AF:
AC:
30
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
12
AN:
1112008
Other (OTH)
AF:
AC:
50
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00213 AC: 324AN: 152338Hom.: 2 Cov.: 31 AF XY: 0.00213 AC XY: 159AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
324
AN:
152338
Hom.:
Cov.:
31
AF XY:
AC XY:
159
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
310
AN:
41578
American (AMR)
AF:
AC:
7
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5176
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68038
Other (OTH)
AF:
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.